CLINICAL BREAST CANCER, cilt.18, sa.4, ss.320-327, 2018 (SCI-Expanded)
Multifocal/multicentric (MF/MC) breast cancer was identified about 10% of all breast cancer. Approximately 4000 breast cancer patients were evaluated and it was found that the MF/MC breast cancer was better T stage classified and more predictive according to T-sum which is the sum of the longest diameters of the lesions. This is more prominent in MF/MC patients with low disease burden.